BioSpace News Archive

Biotech Beach

STAAR Surgical to Present at Stephens Annual Investment Conference (NASH2023)

STAAR Surgical Company, a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses for myopia, astigmatism and presbyopia, announced that management will participate in the Stephens Annual Investment Conference on Thursday, November 16, 2023.

November 15, 2023
·
1 min read
Business

Henlius Reported Financial Results for the First Three Quarters of 2023: Total Revenue Exceeded RMB3.9 billion, Profitability Further Improved

Henlius（2696.HK）announced its financial results and business update for the first three quarters of 2023.

November 15, 2023
·
9 min read
BioCapital

60 Degrees Pharma Announces Type C Meeting with FDA to Discuss Development of Tafenoquine for Babesiosis, an Emerging Tick-Borne Disease

60 Degrees Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted a Type C meeting with the Company to consult on the path forward in developing the tafenoquine regimen of ARAKODA® for a potential indication in treating hospitalized babesiosis patients.

November 15, 2023
·
9 min read
Cybin Announces Poster Presentation at Neuroscience 2023 Annual Meeting

Cybin Inc. today announced a poster presentation at Neuroscience 2023 hosted by the Society for Neuroscience (“SFN”) taking place November 11-15, 2022, in Washington, D.C.

November 15, 2023
·
6 min read
Hemogenyx Pharmaceuticals PLC Announces Lentivirus Re-manufacturing Completed

Hemogenyx Pharmaceuticals plc is pleased to announce the successful completion of the re-manufacturing of an improved lentivirus devoid of splice variants.

November 15, 2023
·
3 min read
Drug Development

RemeGen to Present Telitacicept Phase III Clinical Trial Results for Rheumatoid Arthritis Patients in a Late-Breaking Abstract Oral Presentation Session at the American College of Rheumatology

RemeGen Co., Ltd. is invited to present telitacicept Phase III Clinical Trial Results for Rheumatoid Arthritis Patients in a Late-Breaking Abstract Oral Presentation Session by the American College of Rheumatology.

November 15, 2023
·
3 min read
Business

Myricx Bio Appoints Dr Chris Martin, Biotech Entrepreneur and ADC Pioneer, as Chairman of its Board of Directors

Myricx Bio announces the appointment of Dr Chris Martin as independent Chairman to its Board of Directors.

November 15, 2023
·
4 min read
University of Basel Delivers First Biological Implants for Treatment of Cartilage Lesions and Osteoarthritis in Humans

The Department of Biomedicine at the University of Basel and the University Hospital Basel, announced that it delivered the first surgical procedure to treat Osteoarthritis in humans.

November 15, 2023
·
8 min read
Deals

NanoViricides Has Filed its Quarterly Report - NV-387 Broad-Spectrum Antiviral in Clinical Trials Has Additional Applications

NanoViricides, Inc. (NYSE American: NNVC ) reports that it has filed its Quarterly Report on Form 10-Q for the fiscal first quarter ending September 30, 2023 with the Securities and Exchange Commission (SEC) on Tuesday, November 14, 2023.

November 15, 2023
·
11 min read
Business

Oculis Reports Q3 2023 Financial Results and Provides Company Update

Oculis Holding AG (Nasdaq: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced third quarter financial results for the period ended September 30, 2023, and an overview of the Company’s progress.

November 15, 2023
·
15 min read